Business Segments Orexo AB

Stocks

Market Closed - Nasdaq Stockholm 12:00:00 2026-09-11 EDT			5-day change	1st Jan Change
13.28 ^SEK	-0.90%		-12.29%	-55.88%

09-10	Orexo Secures Additional $3 Million Funding for Opioid Overdose Rescue Medicine	MT
09-10	Orexo gets an additional $3m from BARDA for OX390	FW

Breakdown by Business Segment (SEK)

Fiscal Period: December	2021	2022	2023	2024	2025
Pharmaceutical Products
HQ & Pipeline	41.2M	52.6M	61.1M	29.7M	26M
EBITDA	-	-	-	-	-178M
D&A	19.1M	27.7M	33.3M	39.9M	41M
Operating Income	-243M	-303M	-262M	-168M	-218M
Digital Mental Health Programs	1.1M	400K	100K	-	-
D&A	18.6M	25.7M	28.1M	-	-
Operating Income	-250M	-189M	-131M	-	-
US Commercial	523M	571M	578M	560M	-
EBITDA	-	-	-	-	-108M
D&A	15.4M	15.4M	15.6M	149M	26M
Operating Income	278M	308M	283M	27.9M	-134M
	-	-	-	-	26M
Pharmaceuticals	-	-	-	-	-
Interest Expense	-	-	-	-	-
Income Tax Expense	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EBT	-	-	-	-	-
Gross Profit	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Net Income	-	-	-	-	-

Geographical breakdown of sales (SEK)

Fiscal Period: December	2021	2022	2023	2024	2025
European Union and United Kingdom (EU & UK)	-	-	-	24.5M	22.7M
Rest of The World	4.2M	4.5M	4M	3.8M	2.4M
United States (US)	527M	574M	580M	562M	1M
European Union (EU)	34.1M	45.6M	55M	-	-
	-	-	-	-	22.7M
East Asia	-	-	-	-	-
	-	-	-	-	2.4M
UK	-	-	-	-	-
Sweden	-	-	-	-	-
	-	-	-	-	1M